Document Detail

The role of the MPTP in conditioning the heart - translatability and mechanism.
MedLine Citation:
PMID:  25393318     Owner:  NLM     Status:  Publisher    
Mitochondria have long been known to be the gatekeeper of cell fate. This is particularly so in the response to acute ischaemia-reperfusion injury (IRI). Following an acute episode of sustained myocardial ischaemia, the opening of the mitochondrial permeability transition pore (MPTP) in the first few minutes of reperfusion, mediates cell death. Preventing MPTP opening at the onset of reperfusion using either pharmacological inhibitors (such as cyclosporin-A [CsA]) or genetic ablation has been reported to reduce myocardial infarct (MI) size in animal models of acute IRI. Interestingly, the endogenous cardioprotective intervention of ischaemic conditioning, in which the heart protected against MIby applying cycles of brief ischaemia and reperfusion to either the heart itself or a remote organ or tissue, appears to be mediated through the inhibition of MPTP opening at reperfusion. Small proof-of-concept clinical studies have demonstrated the translatability of this therapeutic approach to target MPTP opening using CsA in clinical settings of acute myocardial IRI. However, given that CsA is a not a specific MPTP inhibitor, more novel and specific inhibitors of the MPTP need to be discovered- the molecular identification of the MPTP should facilitate this. In this article, we review the role of the MPTP as a target for cardioprotection, the potential mechanisms underlying MPTP inhibition in the setting of ischaemic conditioning, and the translatability of MPTP inhibition as a therapeutic approach in the clinical setting.
S-B Ong; Rk Dongworth; H A Cabrera-Fuentes; Dj Hausenloy
Related Documents :
25383678 - Circulating microrna-19a as a potential novel biomarker for diagnosis of acute myocardi...
8809518 - Coronary artery spasm in patients with normal or near normal coronary arteries. long-te...
25488258 - Long-term oral resveratrol intake provides nutritional preconditioning against myocardi...
21253368 - A case of left ventricular pseudoaneurysm in the left atrioventricular groove after mit...
11016488 - Outpatient parenteral inotropic therapy for advanced heart failure.
2645478 - The use of inotropic agents in acute and chronic congestive heart failure.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-13
Journal Detail:
Title:  British journal of pharmacology     Volume:  -     ISSN:  1476-5381     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-11-13     Completed Date:  -     Revised Date:  2014-11-14    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
This article is protected by copyright. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mammalian Non-CpG Methylation: Stem Cells and Beyond.
Next Document:  Controlled dehydration of a ruthenium complex-DNA crystal induces reversible DNA kinking.